Quarry LP’s Third Harmonic Bio THRD Stock Holding History

Quarry LP’s Portfolio THRD Stock Details THRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,000	Closed	-$103K	–	2008
2024 Q4	$103K	Buy	+10,000	New	+$125K	0.01%	433

Other funds holding THRD

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Quarry LP's THRD Position: Q1 2025 in Review

Quarry LP sold out of Third Harmonic Bio (THRD) in Q1 2025, closing a stake of 10,000 shares — an estimated $103K sold.

Quarry LP first reported a position in THRD in Q4 2024 and held it in 1 quarter. The position peaked at $103K in Q4 2024. 99 funds tracked by Wall St. Rank hold THRD as of Q1 2025.

Quarry LP reported no remaining Third Harmonic Bio position as of Q1 2025 after selling out during the quarter.
Quarry LP sold 10,000 Third Harmonic Bio shares in Q1 2025, an estimated $103K.
Quarry LP first reported a position in Third Harmonic Bio in Q4 2024 and held it in 1 quarter.
Quarry LP's Third Harmonic Bio position peaked at $103K in Q4 2024.
99 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q1 2025.

Based on Quarry LP's 13F filing for Q1 2025, filed 15 May 2025.